A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D
About this item
Full title
Author / Creator
MYR 301 Study Group , Wedemeyer, Heiner , Aleman, Soo , Brunetto, Maurizia Rossana , Blank, Antje , Andreone, Pietro , Bogomolov, Pavel , Chulanov, Vladimir , Mamonova, Nina , Geyvandova, Natalia , Morozov, Viacheslav , Sagalova, Olga , Stepanova, Tatyana , Berger, Annemarie , Manuilov, Dmitry , Suri, Vithika , An, Qi , Da, Ben , Flaherty, John , Osinusi, Anu , Liu, Yang , Merle, Uta , Schulze zur Wiesch, Julian , Zeuzem, Stefan , Ciesek, Sandra , Cornberg, Markus and Lampertico, Pietro
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In a randomized trial, 48 weeks of treatment with bulevirtide, which inhibits hepatitis D virus entry into hepatocytes, reduced HDV RNA and alanine aminotransferase levels in patients with chronic hepatitis D.
Alternative Titles
Full title
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D
Authors, Artists and Contributors
Author / Creator
Wedemeyer, Heiner
Aleman, Soo
Brunetto, Maurizia Rossana
Blank, Antje
Andreone, Pietro
Bogomolov, Pavel
Chulanov, Vladimir
Mamonova, Nina
Geyvandova, Natalia
Morozov, Viacheslav
Sagalova, Olga
Stepanova, Tatyana
Berger, Annemarie
Manuilov, Dmitry
Suri, Vithika
An, Qi
Da, Ben
Flaherty, John
Osinusi, Anu
Liu, Yang
Merle, Uta
Schulze zur Wiesch, Julian
Zeuzem, Stefan
Ciesek, Sandra
Cornberg, Markus
Lampertico, Pietro
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_668509
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_668509
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2213429
